Training for Healthcare Providers

Virtual Thalassemia Grand Rounds:  A Virtual Forum for Healthcare Providers
CDC Quality Training Badge

Complications of Thalassemia: Disease Effects and Treatment Effects

April 5, 2 to 3 pm Eastern

See details below or click here to view the recording.external icon

Presenter
Sujit Sheth, MD

Sujit Sheth, MD

Chief, Division of Pediatric
Hematology/Oncology
Professor of Clinical Pediatrics
Weill Cornell Medicine

Moderator
Jennifer Yu, MD

Jennifer Yu, MD

Pediatric Hematologist/Oncologist
Rady Children’s Hospital

Associate Clinical Professor in Pediatrics
UC San Diego School of Medicine

ACTIVITY NUMBER: WC(SC)4468

Origination Date:  October 29, 2021

Expiration Date:  October 29, 2023

Accreditation Statements

Jointly Accredited Provider. Interprofessional Continuing Education.

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and Cooley’s Anemia Foundation. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:  The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE:  The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

Program Description

The thalassemia syndromes are a group of hereditary disorders in the synthesis of hemoglobin that result in varying degrees of anemia. Treatment for severe cases typically includes red blood cell transfusion and iron chelation therapy. Management of thalassemia is complex and may present many challenges to overcome.  For example, complications may occur as a result of the underlying disease process as well as the treatment regimen.

In these rounds, Sujit Sheth, MD, will discuss the pathophysiology of complications of thalassemia in both transfused and non-transfused individuals. All of these complications will be discussed in depth, and a monitoring and treatment management plan will be presented.

Target Audience

The target audience for these rounds are physicians, physician assistants, nurses, nurse practitioners, and other healthcare professionals.

Course Content

The live rounds is presented for 60 minutes, including a pre-test and post-test.

Learning Objectives

At the conclusion of the rounds, participants will be able to do the following:

  1. Describe three disease complications in treated and untreated patients with thalassemia.
  2. Describe three complications of treatment of the disease.
  3. Describe a rational monitoring and treatment management plan for thalassemia.

Contact Information

For more information, please contact Cynthia Sayers at cay1@cdc.gov

This project was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $150,000 with 100 percent funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.